Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-006794
Filing Date
2022-06-23
Accepted
2022-06-23 16:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28961
2 filename2.txt TEXT-EXTRACT 3445
  Complete submission text file 0000000000-22-006794.txt   44167
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filed for) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)